AGDA KARINA B. ETEROVIC to Drug Resistance, Neoplasm
This is a "connection" page, showing publications AGDA KARINA B. ETEROVIC has written about Drug Resistance, Neoplasm.
Connection Strength
0.272
-
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin Cancer Res. 2009 Jul 15; 15(14):4589-99.
Score: 0.062
-
Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system. J Neurooncol. 2007 Oct; 85(1):1-10.
Score: 0.053
-
Drug-resistance in central nervous system tumors: from the traditional cell-resistance model to the genetically driven approaches on therapy. Curr Pharm Biotechnol. 2007 Apr; 8(2):105-13.
Score: 0.053
-
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS One. 2015; 10(9):e0136851.
Score: 0.047
-
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors. Oncotarget. 2014 Sep 30; 5(18):8544-57.
Score: 0.044
-
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Sci Transl Med. 2017 05 31; 9(392).
Score: 0.013